Diagnosis and Treatment of Sensorineural Hearing Loss with Vertigo
MRI with dedicated internal auditory canal (IAC) protocol is the first-line imaging modality for diagnosing the cause of sensorineural hearing loss with vertigo, followed by appropriate treatment based on the identified etiology. 1, 2
Diagnostic Approach
Clinical Evaluation
- Assess hearing loss characteristics:
- Sudden vs. gradual onset
- Unilateral vs. bilateral
- Fluctuating vs. stable
- Associated symptoms (tinnitus, aural fullness)
- Evaluate vertigo features:
- Episodic vs. continuous
- Positional triggers
- Duration of episodes
- Presence of nystagmus
Differential Diagnosis
- Menière's disease: Fluctuating hearing loss, episodic vertigo, tinnitus, aural fullness 1
- Labyrinthitis/Labyrinthine infarction: Sudden hearing loss with acute vertigo 3
- Vestibular schwannoma: Progressive unilateral hearing loss with imbalance 1
- Autoimmune inner ear disease: Bilateral fluctuating hearing loss 1
- Endolymphatic hydrops: Altered ratio of endolymph to perilymph 2
- AICA infarction: Sudden hearing loss with vertigo and neurological symptoms 3
Diagnostic Testing
Imaging
MRI Head and Internal Auditory Canal (first-line):
CT Temporal Bone (complementary):
Audiological Testing
- Pure tone audiometry to characterize hearing loss pattern
- Speech discrimination testing
- Tympanometry to rule out middle ear pathology
Vestibular Testing
- Electronystagmography (ENG) - prognostic value for recurrence and progression to Menière's disease 4
- Video head impulse test (vHIT) - assess semicircular canal function 3
- Vestibular evoked myogenic potentials (VEMPs) - evaluate otolith function 3
Treatment Approach
Medical Management
Corticosteroids:
- First-line treatment for sudden sensorineural hearing loss
- Short course of high-dose oral steroids (e.g., prednisone)
- Consider intratympanic steroid injections for refractory cases 5
Symptomatic Management of Vertigo:
- Meclizine: 25-100 mg daily in divided doses for acute vertigo
- Caution: May cause drowsiness, dry mouth, and blurred vision
- Contraindicated in patients with hypersensitivity to meclizine
- Use with caution in patients with asthma, glaucoma, or prostate enlargement 6
- Other vestibular suppressants: diazepam, promethazine as needed
- Meclizine: 25-100 mg daily in divided doses for acute vertigo
Disease-Specific Treatments:
- Menière's disease: Low-salt diet, diuretics, intratympanic gentamicin for refractory cases
- Autoimmune inner ear disease: Immunosuppressive therapy
- Labyrinthitis: Antibiotics if bacterial etiology is suspected
Surgical Management
- Reserved for cases refractory to medical management or specific pathologies:
- Vestibular schwannoma resection
- Endolymphatic sac decompression for Menière's disease
- Ablative procedures (labyrinthectomy, vestibular neurectomy) for disabling vertigo 7
Prognostic Factors
- Presence of spontaneous nystagmus on initial ENG indicates higher risk of recurrent hearing loss (51.2% vs. 27.9%) and progression to Menière's disease (14%) 4
- Posterior semicircular canal dysfunction is common (74%) in patients with vertigo and sudden hearing loss 3
- Approximately 50% of patients with sudden sensorineural hearing loss recover completely within 2 weeks 5
- Bilateral sudden hearing loss has worse prognosis and requires thorough evaluation for systemic causes 1
Common Pitfalls to Avoid
- Relying on standard head CT instead of dedicated temporal bone imaging or MRI
- Failing to recognize that vertigo with SSNHL may represent a vascular emergency (AICA infarction)
- Missing the diagnosis of vestibular schwannoma by not obtaining appropriate imaging
- Overlooking the prognostic value of vestibular testing in predicting recurrence and progression
- Delaying treatment of sudden sensorineural hearing loss, which can reduce recovery potential